Phone tuning company Paratek Microwave exits after raising an estimated $91.4m in its history.
Month: March 2012
Bats eyes up to $113.3m in IPO
The exchange owned by a number of big US banks and trading companies sets the range for a flotation which will see it trade on its own exchange.
BASF helps take Allylix to $18.2m
Tate & Lyle Ventures invests again, having backed the company since 2007, while BASF Venture Capital takes more than two thirds of the latest round.
Dealised repositions as Asia-Pac company
Dealised sells off its UK operations and makes an Asian push, less than a year after receiving backing from SingTel’s corporate venturing unit.
Intel-backed Aldebaran sells stake for $100m
Intel Capital’s first deal in the robotics industry heads to Japan after a C round last year.
Happiest Minds opens in UK
The India-based IT company follows up a $45m round from investors including Intel Capital, opening a UK office.
Blackstone adopts WatchDox technology, invests
The New York-listed alternative asset manager adopts security technology WatchDox and invests in the company in a corporate venturing-style deal.
Minority Report company raises $21m
Oblong Industries, a visual software company co-founded by the scientist who developed the technology used in the Steven Spielberg film, raises the funds from Energy Technology Ventures and Morgan Stanley Alternative Investment Partners.
Turner sets up accelerator
The Time Warner-owned media business launches an accelerator.
MCX’s IPO pops 25.7%
The Intel Capital-backed exchange saw a 25.7% pop, in the first listing of an Indian exchange in the country.
Citi Ventures backs InvestLab
US-based bank’s corporate venturing unit backs Hong Kong-based trading company founded two years ago.
Intel helps Virtustream raise $15m
The US-based cloud enterprise company says the latest round has taken it to $75m raised in total.
Boston Scientific option wins Cameron Health’s heart
Boston Scientific exercises an option it acquired in 2004 as part of a corporate venturing deal to buy heart treatment company Cameron Health for up to $1.35bn.
TPG plans $500m clean-tech fund
The Alternative & Renewable technologies (Art) fund is to complement TPG’s existing biotech funds and the broader leveraged buyout portfolios.